Subscribe To
Enphase energy: a deep dive into the solar market trends (rating upgrade)
Enphase is now down over 45% from its all-time high in December, as the market is concerned about its ...
June 19, 2023, 1:34 am
Eurusd weekly analysis – june 18, 2023
The EURUSD currency pair has been trading in a relatively narrow range between 1.0515 and 1.1095, displaying a period of consolidation in recent sessi...
June 18, 2023, 7:34 am
Lantheus: pylarify and definity driving strong growth
Lantheus is growing revenue and earnings at an above-average pace. The strong pipeline of phase 3 compo...
June 18, 2023, 3:54 am
One-year data from phase 3 trial of transcon™ pth in adults with hypoparathyroidism presented at endo 2023
– Oral presentation of results showed sustained improvements through Week 52, as well as safety and tolerability similar to that previously reported...
June 17, 2023, 9:30 pm
Rhythm pharmaceuticals presents data demonstrating bmi reduction in patients with hypothalamic obesity treated with setmelanotide over six months at endo 2023
— Mean BMI reduction of 21.0% from baseline observed in 13 patients at six months, showing progression from 16.8% mean BMI reduction at 16 weeks —...
June 17, 2023, 6:01 pm
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Merck: approaching the accumulation phase with an expanding product portfolio
Keytruda sales totaled $5,795 million in Q1 2023, up 17% year-on-year, thanks partly to an increase in its indications for use. At the same time, Robe...
June 17, 2023, 1:57 am
1 green flag for fisker stock investors
The innovative EV company is ready for its next phase....
June 16, 2023, 4:39 pm
Gold price analysis: testing support levels amidst consolidation and breakout attempts
Technical analysis reveals a retracement in gold, testing key support zones and indicating a healthy consolidation ...
June 16, 2023, 4:22 pm
Aldeyra's stellar allergic conjunctivitis results to raise reproxalap monetization value
Aldeyra Therapeutics reported positive results from a phase III study of Reproxalap, an eye drop drug f...
June 16, 2023, 10:55 am
Bt rival hyperoptic sacks 100 engineers in latest altnet redundancy round
BT Openreach rival Hyperoptic is the latest altnet broadband provider to announce layoffs, with over 100 engineers expected to lose their jobs accordi...
June 16, 2023, 9:25 am
Usd/cad holds steady above 1.3200/ytd low, upside potential seems limited
The USD/CAD pair enters a bearish consolidation phase on Friday and oscillates in a narrow trading band...
June 16, 2023, 8:44 am
Immunic has a blockbuster clinical pipeline to treat multiple sclerosis and gastrointestinal diseases
New York-based biotechnology company Immunic Inc (NASDAQ:IMUX) has one or more potential blockbusters in its clinical pipeline. The firm's promising l...
June 16, 2023, 8:01 am
Biotech executive michael smith discusses the fda drug development process with cancervax ceo ryan davies
Michael Smith comments on the growth of immunotherapy and sees the required FDA development phases as a benefit to small biotech firms such as CancerV...
June 16, 2023, 7:01 am
Amazon debuts its headquarters complex in virginia as it brings workers back to office
Amazon unveiled the first phase of its new headquarters complex in Virginia Thursday, a pair of gleamin...
June 16, 2023, 3:14 am